NIH

VU study sheds new light on DNA replication

David Cortez, Ph.D., and his Vanderbilt colleagues report new findings that shed light on fundamental processes involved in DNA replication and have implications for cancer therapies that target these processes.

Preserving antibiotic arsenal for TB

Clinicians should be cautious about prescribing newer fluoroquinolone antibiotics to patients with TB risk factors; doing so may jeopardize the use of these agents against TB.

Tool predicts risk for developmental delays in early childhood

A non-invasive measure of electrical brain activity in preterm infants predicts cognitive and communication functioning during early childhood, according to a new Vanderbilt University study.

Targets of SIN drive cell division

Vanderbilt researchers have identified a key regulator of cell division.

Shining a light on night blindness

Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness.

stethoscope and money

Pharmacogenomic testing costs studied

A research team led by Josh Peterson, M.D., MPH, assistant professor of Biomedical Informatics and Medicine, and John Graves, Ph.D., assistant professor of Preventive Medicine, will study the cost-effectiveness of testing patients’ risk of adverse gene-drug interactions.

1 75 76 77 78 79 101